Obesity-related cardio-metabolic risks are characterized by hyperinsulinemia (i.e. basal plasma insulin levels >7–10 μU/mL), hypertriglyceridemia, elevated biomarkers of inflammation, and high blood pressure. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.